AAME ATLANTIC AMERICAN CORP
Life Insurance · Nasdaq · SEC CIK 8177 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (2025Q4), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.8%
TTM net income YoY241.0%
TTM EPS YoY411.1%
Revenue 3-yr CAGR3.9%
Net income 3-yr CAGR58.0%
Margins
Gross margin—
Operating margin—
Net margin2.9%
FCF margin15.4%
EBITDA margin—
Returns
ROE5.2%
ROA1.5%
ROIC (approx.)—
Asset turnover0.52x
Leverage & solvency
Liabilities / assets72.2%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income5.46x
Accruals ratio-6.6%
Payout ratio—
Capex / revenue0.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $210.44M | $188.08M | $186.79M | $187.85M | $199.55M |
| Operating income | $3.70M | -$1.32M | $1.54M | $9.63M | -$1.50M |
| Interest expense | $3.08M | $3.42M | $3.27M | $1.95M | $1.39M |
| Pretax income | $7.72M | -$1.62M | -$565,000 | $2.10M | $5.30M |
| Income tax | $1.70M | -$232,000 | -$394,000 | $571,000 | $1.02M |
| Net income | $6.02M | -$1.39M | -$171,000 | $1.52M | $4.28M |
| EBITDA | $4.14M | -$953,000 | $2.19M | $10.52M | -$492,000 |
| EPS (basic) | 0.28 | -0.09 | -0.03 | 0.06 | 0.19 |
| EPS (diluted) | 0.28 | -0.09 | -0.03 | 0.06 | 0.19 |
| Dividends declared per share | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Weighted avg. shares (diluted) | 20.40M | 20.40M | 20.40M | 20.39M | 20.40M |
| Banking | |||||
| Provision for credit losses | -$27,000 | -$4,000 | $26,000 | $0 | — |
| Balance sheet | |||||
| Cash & equivalents | $43.64M | $35.57M | $28.30M | $28.86M | $24.75M |
| Total assets | $433.94M | $382.04M | $378.53M | $367.06M | $402.29M |
| Total liabilities | $313.15M | $271.47M | $273.99M | $264.87M | $261.00M |
| Shareholders' equity | $120.79M | $110.57M | $106.07M | $102.19M | $141.29M |
| Shares outstanding | 20.40M | 20.40M | 20.40M | 20.41M | 20.38M |
| Cash flow statement | |||||
| Operating cash flow | $32.87M | $4.80M | $2.62M | $6.45M | $1.09M |
| Capital expenditure | $466,000 | $225,000 | $80,000 | $126,000 | $107,000 |
| Free cash flow | $32.41M | $4.58M | $2.54M | $6.33M | $981,000 |
| Investing cash flow | -$25.00M | $2.28M | -$3.37M | -$3.43M | $5.30M |
| Financing cash flow | $189,000 | $186,000 | $181,000 | $1.08M | -$954,000 |
| Depreciation & amortization | $438,000 | $366,000 | $652,000 | $890,000 | $1.00M |
| Stock-based compensation | $2,000 | $11,000 | $119,000 | $134,000 | $211,000 |
| Dividends paid | $408,000 | $408,000 | $408,000 | $408,000 | $408,000 |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.